Skip to main content
SpringerLink
Log in

Neue Entwicklungen in der Behandlung von Infektionskrankheiten

  • Conference paper
Verhandlungen der Deutschen Gesellschaft für innere Medizin

Part of the book series: Verhandlungen der Deutschen Gesellschaft für innere Medizin ((VDGINNERE,volume 87))

  • 29 Accesses

Zusammenfassung

Prospektive Studien über den Einsatz von Antibiotika in Klinik und Praxis wurden bisher vor allem in den USA durchgeführt. Diese, wie auch die vereinzelten europäischen Untersuchungen zeigen, daß 25–30% der hospitalisierten Patienten Antibiotika erhalten, wobei ca. 50% aus therapeutischen und ca. 50% aus prophylaktischen Indikationen verschrieben werden. Je nach der Strenge der Beurteilungskriterien der Autoren wurden 20–60% der Therapien und Prophylaxen inadäquat durchgeführt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Eijsten A, Lüthy R, Akovbiantz A (1979) Antibiotikaverbrauch an einer chirurgischen Klinik. Schweiz Med Wochenschr 109: 1931–1936

    PubMed  CAS  Google Scholar 

  2. Simmen HP, Lüthy R, Siegenthaler W (1981) Antibiotikaeinsatz in der ambulanten Praxis. Ergebnisse und Gedanken zu einer Umfrage bei praktizierenden Ärzten im Kanton Zürich. Schweiz Med Wochenschr 111: 4–10

    Google Scholar 

  3. Baker CN, Thornsberry C, Jones RN (1980) In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam, azlocillin, mezlocillin and other betalactam antibiotics against Neisseria gonorrhoea and Haemophilus influenzae, including betalactamase producing strains. Antimicrob Agents Chemother 17: 757

    Article  PubMed  CAS  Google Scholar 

  4. Bonetti A (1981) Cephalosporine. In: „Medizin and Pharmazie“.Schweiz Apoth Ztg 119 (im Druck)

    Google Scholar 

  5. Eijsten A, Lüthy R, Akovbiantz A (1979) Antibiotikaverbrauch an einer chirurgischen Klinik. Schweiz Med Wochenschr 109: 1931

    PubMed  CAS  Google Scholar 

  6. Fu KP, Neu HC (1978) Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother 13: 358

    Article  PubMed  CAS  Google Scholar 

  7. Grimm H (1981) Persönliche Mitteilung

    Google Scholar 

  8. Lode H, Siegenthaler W (1981) Klinische Antibiotika-Therapie. Empfehlung einer interdisziplinären Arbeitsgruppe der Paul-Ehrlich-Gesellschaft für Chemotherapie. Dtsch Ärztebl 194: 501

    Google Scholar 

  9. Lüthy R (1980) Basis for an adequate dosage of aminoglycoside antibiotics. Infection 8: 558

    Article  Google Scholar 

  10. Lüthy R (1980) Basis for an adequate dosage of aminoglycoside antibiotics. Infection 8: 558

    Article  Google Scholar 

  11. Munch R (1981) Penicilline. In: „Medizin und Pharmazie“. Schweiz Apoth Ztg 119 (im Druck)

    Google Scholar 

  12. Mönch R (1981) Tetrazykline. In: „Medizin und Pharmazie“. Schweiz Apoth Ztg 119 (im Druck)

    Google Scholar 

  13. Neu HC (1977) The penicillins. NY State J Med 768: 962

    Google Scholar 

  14. Rahal JJ Jr (1978) Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine 57: 197

    Article  Google Scholar 

  15. Rieder H (1981) Aminoglykosid-Antibiotika. In: „Medizin und Pharmazie“. Schweiz Apoth Ztg 119 (im Druck)

    Google Scholar 

  16. Siegenthaler W, Fuchs P, Lüthy R (1979) Die Chemotherapie bakterieller Pneumonien. Atemwegs- Lungenkrankh 5: 386

    Google Scholar 

  17. Siegenthaler W, Fuchs P, Lüthy R (1981) Die Prophylaxe bakterieller Infektionen. Internist 22: 57

    PubMed  CAS  Google Scholar 

  18. Simmen HP (1981) Erythromycin. In: „Medizin und Pharmazie“. Schweiz Apoth Ztg 119 (im Druck)

    Google Scholar 

  19. Simmen HP (1981) Anaerobier-Chemotherapeutika. In: „Medizin und Pharmazie“. Schweiz Apoth Ztg 119 (im Druck)

    Google Scholar 

  20. Simmen HP, Lüthy R, Siegenthaler W (1981) Antibiotikaeinsatz in der ambulanten Praxis. Schweiz Med Wochenschr 111: 4

    PubMed  CAS  Google Scholar 

  21. Austrian R, Douglas RM, Schiffman G, Coetzee AM, Koornhof HJ, Hayden-Smith S, Reid RDW (1976) Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 89: 184–194

    PubMed  CAS  Google Scholar 

  22. Bille J, Glauser MP, Freedman LR (1980) Risk of death in adult pneumococcal bacteremia. In: Pneumonia and pneumococcal infections: Royal Society of Medicine International Congress and Symposium, Series no 27. Ltd. and the Royal Society of Medicine. Academic Press, London, pp 47–52

    Google Scholar 

  23. Broome CV, Facklam RR, Fraser DW (1980) Pneumococcal disease after pneumococcal vaccination. An alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303: 549–552

    Google Scholar 

  24. Chedid L, Parant M., Parant F, Boyer F (1968) A proposed mechanism for natural immunity to enterobacterial pathogens. J Immunol 100: 292–301

    PubMed  CAS  Google Scholar 

  25. Francioli P, Schaller MD, Glauser MP (1981) Sepsis fulminantes à S. pneumoniae après splenectomie: à propos de 4 cas. Schweiz Med Wochenschr (to be published)

    Google Scholar 

  26. Heath EC, Mayer RM, Edstron RD, Beaudreau CA (1966) Structure and biosynthesis of the cell wall lipopolysaccharide of Escherichiacolt. Ann NY Acad Sci 133: 315–333

    Article  PubMed  CAS  Google Scholar 

  27. Hosea SW, Brown EJ, Hamburger MI, Frank MM (1981) Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 304: 245–250

    Article  PubMed  CAS  Google Scholar 

  28. Luderitz O, Galanos C, Risse HJ, Ruschmann E, Schlecht S, Schmidt G, Schulte-Holthausen H, Wheat R, Westphal 0 (1966) Structural relationships of Salmonella O and R antigens. Ann NY Acad Sci 133: 349–374

    Article  CAS  Google Scholar 

  29. McCabe WR (1972) Immunization with R mutants of S. minnesota. I. Protection against challenge with heterologous Gram-negative bacilli. J Immunol 108: 601–610

    PubMed  CAS  Google Scholar 

  30. McCutchan JA, Ziegler EJ, Braude AI (1979) Treatment of Gram-negative bacteremia with antiserum to core glycolipid. II. A controlled trial of antiserum inpatients with bacteremia. EurJ Cancer 15: 77–80

    Google Scholar 

  31. Minor DR, Schiffman G, McIntosh LS (1979) Response of patients with Hodgkins Disease to pneumococcal vaccine. Ann Intern Med 90: 887–892

    Article  PubMed  CAS  Google Scholar 

  32. Osborn MJ (1966) Biosynthesis and structure of the core region of the lipopolysaccharide in Salmonella typhimurium. Ann NY Acad Sci 133: 375–383

    Article  PubMed  CAS  Google Scholar 

  33. Singer DB (1973) Postsplenectomy sepsis. In: Rosenberg HS, Belaude RP (eds) Perspectives in pediatric pathology. Year Book Medical Publ., Chicago, pp 285–311

    Google Scholar 

  34. WolfJL, McCutchanJA, Ziegler EJ, Braude AI (1980) Prophylactic antibody to core lipopolysaccharide in neutropenia. In: Nelson JD, Grassi C (eds) Current chemotherapy and infectious diseases. American Society of Microbiology, pp 1439–1441

    Google Scholar 

  35. Ziegler EJ, McCutchan JA, Braude AI (1979) Treatment of Gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin. Eur J Cancer 15: 71–76

    Google Scholar 

  36. Ziegler EJ, McCutchan JA, Douglas E, Braude AI (to be published) Successful treatment of human Gram-negative bacteremia with antiserum against endotoxin core.

    Google Scholar 

  37. Al-Awadi AR, Mahler H (1980) Declaration of the 33rd World Health Assembly. WHO Wkly Epidem Rec 55: 148

    Google Scholar 

  38. Arita I (1979) Virological evidence for the success of the smallpox eradication programme. Nature 279: 293–298

    Article  PubMed  CAS  Google Scholar 

  39. Bundesgesundheitsamt (1981) Bericht über die 18. Sitzung der Ständigen Impfkommission des Bundesgesundheitsamtes. Bundesgesundheitsbl 24: 111–112

    Google Scholar 

  40. Cros-nier J, Jungers P, Couroucé AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P (1981) Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I. Medical staff. Lancet 1: 455–459

    Google Scholar 

  41. Deinhardt F (1978) Hepatitisbekämpfung Menschliches Immunserumglobulin und Hepatitis B. Bundesgesundheitsbl 21: 89–91

    Google Scholar 

  42. Deinhardt F (1980) Predictive value of markers of hepatitis virus infection. J Infect Dis 141: 299–305

    Article  PubMed  CAS  Google Scholar 

  43. Deinhardt F (1981) Ätiologie und Pathogenese der Virushepatitiden. Thieme, Stuttgart New York (im Druck )

    Google Scholar 

  44. Deinhardt F, Scheid R, Gauss-Müller V, Frösner G, Siegl G (1981) Propagation of human hepatitis A virus in cell lines of primary human hepatocellular carcinomas. In: Melnick JL (ed) Progr Med Virol, vol 27. Karger, Basel München Paris London New York Sydney, p 109

    Google Scholar 

  45. Deinhardt F, Zachoval R, Schmidt M, Frösner H, Frösner G (1981) Active and passive-active immunization against hepatitis virus infection. In: Maupas P, Guesry P (eds) INSERM Symposium no. 18. Elsevier/North Holland Biomedical Press, p 167

    Google Scholar 

  46. Deinhardt F, Spiess H (1981) Der praenatale und perinatale Virusinfekt. Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e. V. und Deutsches Grünes Kreuz, München Marburg

    Google Scholar 

  47. Ehrengut W, Kuwert E, Thomssen R (1981) Minderheitsvotum zur Rötelnimpfung. Bundesgesundheitsbl 24: 112

    Google Scholar 

  48. Flehmig B (1980) Hepatitis A virus in cell culture. I. Propagation of different hepatitis A virus isolates in a fetal rhesus monkey kidney cell line (Frhk-4). Med Microbiol Immunol 168: 239–248

    Article  PubMed  CAS  Google Scholar 

  49. Flehmig B (1980) Hepatitis A virus in cell culture. I. Propagation of different hepatitis A virus isolates in a fetal rhesus monkey kidney cell line (Frhk-4). Med Microbiol Immunol 168: 239–248

    Article  PubMed  CAS  Google Scholar 

  50. Gerety RJ, Tabor E (1979) Summary of an international workshop on hepatitis B vaccines. J Infect Dis 140: 642–648

    Article  PubMed  CAS  Google Scholar 

  51. Gerety RJ, Smallwood LA, Tabor E (1980) Hepatitis B immune globulin and immune serum globulin. N Engl J Med 303: 529

    PubMed  CAS  Google Scholar 

  52. Maupas P, Guesry P (1981) Hepatitis B vaccine. INSERM Symposium no 18. Elsevier/North Holland Biomedical Press

    Google Scholar 

  53. Hilleman MR, Bertland AN, Buynak EB, Lampson JP, McAleer WJ, McLean AA, Roehm RR, Tytell AA (1978) Clinical and laboratory studies of HBsAg vaccine. In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis. Franklin Institute Press, Philadelphia, p 525

    Google Scholar 

  54. Spiess H (1977) Immunoglobuline in Prophylaxe und Therapie. Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e. V. und Deutsches Grünes Kreuz, München Marburg

    Google Scholar 

  55. Krugman S, Giles JP, Hammond J (1971) Viral hepatitis type B (MS-2 strain): studies on active immunization. JAMA 217: 41–45

    Article  PubMed  CAS  Google Scholar 

  56. Krugman S, Giles JP (1973) Viral hepatitis type B (MS-2 strain): further observations on natural history and prevention. N Engl J Med 288: 755–760

    Article  PubMed  CAS  Google Scholar 

  57. Kuwert EK (1978) Tollwutschutzimpfung mit HDCS-Gewebekulturvakzine. Dtsch Ärztebl 25: 1495–1501

    Google Scholar 

  58. Locarnini SA, Coulepis AG, Westaway EG, Gust ID (1981) Restricted replication of human hepatitis A virus in cell culture: Intercellular biochemical studies. J Virol 37: 216–225

    Google Scholar 

  59. Maupas P, Coursaget P, Goudeau A, Drucker J (1976) Immunization against hepatitis B in man. Lancet 1: 1367–1370

    Article  PubMed  CAS  Google Scholar 

  60. Maupas P, Goudeau A, Coursaget P, Drucker J, Barin F, André M (1978) Immunization against hepatitis B in man: a pilot study of two years’ duration. In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis. Franklin Institute Press, Philadelphia, p 539

    Google Scholar 

  61. Maupas P, Barin F, Chiron JP, Coursaget P, Goudeau A, Perrin J, Denis F, Diop Mar I (1981) Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area ( Senegal ). Lancet 1: 289–292

    Google Scholar 

  62. McAuliffe VJ, Purcell RH, Gerin JL (1980) Type B hepatitis: a review of current prospects for a safe and effective vaccine. Rev Infect Dis 2: 470–492

    Article  PubMed  CAS  Google Scholar 

  63. Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P, Leadbetter G, Murray K (1979) Hepatitis B virus genes and their expression in E. coli. Nature 282: 575–579

    Article  CAS  Google Scholar 

  64. Provost PJ, Hilleman MR (1979) Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med 160: 213–221

    Article  PubMed  CAS  Google Scholar 

  65. Rubella United States, 1977–1980 (1980) MMWR 29: 379–380

    Google Scholar 

  66. Schober A (1978) Passive Immunprophylaxe der Hepatitis B. Bundesgesundheitsbl 21: 327–376

    Google Scholar 

  67. Seidl S (1978) Zum derzeitigen Stand der Immunprophylaxe der Hepatitis B. Bundesgesundheitsbl 21: 91–93

    Google Scholar 

  68. Siddiqui A, Sattler F, Robinson WS (1979) Restriction endonuclease cleavage map and location of unique features of the DNA of hepatitis B virus, subtype adw2. Proc Natl Acad Sci USA 76: 4664–4668

    Article  PubMed  CAS  Google Scholar 

  69. Siegl G, Frösner G (1978a) Characterization and classification of virus particles associated with hepatitis A. I. Size, density, and sedimentation. J Virol 26: 40–47

    Google Scholar 

  70. Siegl G, Frösner G (1978b) Characterization and classification of virus particles associated with hepatitis A. II. Type and configuration of nucleic acid. J Virol 26: 48–53

    Google Scholar 

  71. Siegl G, Frösner G (1978b) Characterization and classification of virus particles associated with hepatitis A. II. Type and configuration of nucleic acid. J Virol 26: 48–53

    Google Scholar 

  72. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A (1980) Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 303: 833–841

    Google Scholar 

  73. Szmuness W, Oleszko WR, Stevens CE, Goodman A (1981) Passive-active immunisation against hepatitis B: immunogenicity studies in adult Americans. Lancet 1: 575–577

    Article  PubMed  CAS  Google Scholar 

  74. Tratschin JD, Siegl G, Frösner G, Deinhardt F (1981) Characterization and classification of virus particles associated with hepatitis A. III. Structural proteins. J Viro! 38: 151–156

    Google Scholar 

  75. Valenzuela P, Gray P, Quiroga M, Zaldivar J, Goodman HM, Rutter WJ (1979) Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature 280: 815–819

    Article  PubMed  CAS  Google Scholar 

  76. Viral respiratory diseases. Report of a WHO Scientific Group (1980). World Health Organization Technical Report Series 642

    Google Scholar 

  77. von der Helm K, Winnacker EL, Deinhardt F, Bayerl B, Frösner G, Gauss-Müller V, Scheid R, Siegl G (1981) Cloning of the hepatitis A virus genome. J Virol Methods (in press)

    Google Scholar 

  78. Zachoval R, Frösner G, Deinhardt F (1981) Impfung gegen Hepatitis B. Ergebnisse einer Immunogenitätsstudie. Münch Med Wochenschr (im Druck )

    Google Scholar 

  79. Zuckerman AJ (1981) Hepatitis B: its prevention by vaccine. J Infect Dis 143: 301–304

    Article  PubMed  CAS  Google Scholar 

  80. Block LH, Georgopoulos A, Mayer P, Drews J (1978) Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8. J Exp Med 148: 1228–1240

    Article  PubMed  CAS  Google Scholar 

  81. Dale BC, Wolff SM (1971) Skin window studies of the acute inflammatory responses of neutropenic patients. Blood 38: 138–142

    PubMed  CAS  Google Scholar 

  82. Drews J (1980a) A role for immune stimulation in the treatment of microbial infections? Infection 8: 2–4

    Article  PubMed  CAS  Google Scholar 

  83. Drews J (1980b) Möglichkeiten der Immunstimulation. Swiss Pharma 2: 49–56

    Google Scholar 

  84. Dubos R, Schaedler RW (1956) Reversible changes in the susceptibility of mice to bacterial infections. J Exp Med 104: 53–65

    Article  PubMed  CAS  Google Scholar 

  85. Fauve RM, Hevin B (1974) Immunostimulation with bacterial phospholipid extracts. Proc Natl Acad Sci USA 71: 573

    Article  PubMed  CAS  Google Scholar 

  86. van Furth R (1974) Activation of macrophages. Excerpta Medica, Amsterdam

    Google Scholar 

  87. Gupta RC, Robinson WA, Kurnick JE (1976) Felty’s syndrome. Effect of lithium on granulopoiesis. Am J Med 61: 29–31

    Google Scholar 

  88. Kokoshis PL, Williams DL, Cook JA, Di Luzio NR (1978) Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science 199: 1340–1342

    Article  PubMed  CAS  Google Scholar 

  89. Levitt LI, Quesenberry PJ (1980) The effect of lithium on mutine hematopoiesis in a liquid culture system. N Engl J Med 302: 713–719

    Article  PubMed  CAS  Google Scholar 

  90. Lyman GH, Williams CC, Preston D (1980) The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. N Eng J Med 302: 257–260

    Article  CAS  Google Scholar 

  91. Mayer P, Drews J (1980) The effect of a protein-bound polysaccharide from Coriolus versicolor on immunological parameters and experimental infections in mice. Infection 8: 13–21

    Article  PubMed  CAS  Google Scholar 

  92. Mayer P, Hamberger H, Drews J (1980) Differential effects of ubiquinone Q7 and ubiquinone analogs on macrophage activation and exerpimental infections in granulocytopenic mice. Infection 8: 256–261

    Article  CAS  Google Scholar 

  93. Mayer P (unveröffentlichte Ergebnisse) Rothstein G, Clarkson DR, Larsen W, Grosser BI, Athens JW (1978) Effect of lithium on neutrophil mass and production. N Engl J Med 298: 178–180

    Article  Google Scholar 

  94. Singer C (1980) Infections in patients with neoplastic diseases. In: Grieco MM (ed) Infections in the abnormal host. Yorke Medic. Books, New York, pp 546–584

    Google Scholar 

  95. Lau WK, Joung LS (1976) Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N Engl J Med 295: 716–721

    Article  PubMed  CAS  Google Scholar 

  96. Hughes WT, Feldman S, Sangal SH (1975) Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole. Can Med Assoc J [Suppl] 112: 47–51

    CAS  Google Scholar 

  97. Fiala M, Payner JE, Berne TV (1975) Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis 132: 421–426

    Article  PubMed  CAS  Google Scholar 

  98. Meyers JD, Spencer HC, Wattschat J (1975) Cytomegalovirus pneumonia after human marrow transplantation. Ring Intern Med 82: 181–185

    Google Scholar 

  99. Fraser DW, Tsai TR, Orenstein W, Parkin WE, Beecham HJ, Sharran RG, Harnis J, Mallison GF, Martin SM, McDade JE, Shepard CC, Brachman PS (1977) Legionnaires’ disease. Description of an epidemic of pneumonia. N Engl J Med 297: 1189–1197

    Google Scholar 

  100. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR (1977) Legionnaires’ disease. Isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 297: 1197–1203

    Google Scholar 

  101. Cordes LG, Fraser DF (1980) Legionellosis. Med Clin North Am 64: 395–416

    CAS  Google Scholar 

  102. Flesher AR, Kasper DL, Modern PA, Mason EO (1980) Legionella pneumophila: Growth inhibition by human pharyngeal flora. J Infect Dis 142: 313–317

    Google Scholar 

  103. Swartz MN (1979) Clinical aspects of Legionnaires’ disease. Ann Intern Med 90: 492–495

    Article  PubMed  CAS  Google Scholar 

  104. Glick TH, Gregg MB, Beoman B, Mallison G, Rodes WW, Hassanoff J (1978) Pontiac fever: An epidemic of unknown etiology in a health department. Am J Epidemiol 107: 149–160

    Google Scholar 

  105. Tsai TF, Finn DR, Plikaytis BD, McCauley W, Martin SM, Fraser DW (1979) Legionnaires’ disease: Clinical features of the epidemic in Philadelphia. Ann Intern Med 90: 509–517

    Google Scholar 

  106. Dietrich PA, Johnson RD, Fairbanks JT, Walke JS (1978) The chest radiograph in Legionnaires’ disease. Radiology 127: 577–582

    PubMed  CAS  Google Scholar 

  107. Helms CM, Viner JP, Sturm RH, Renner ED, Johnson W (1979) Comparative features of pneumococcal, mycoplasmal, and Legionnaires’ disease pneumonias. Ann Intern Med 90: 543–547

    Article  PubMed  CAS  Google Scholar 

  108. Miller AC (1979) Early clinical differentiation between Legionnaires’ disease and other sporadic pneumonias. Ann Intern Med 90: 526–528

    Article  PubMed  CAS  Google Scholar 

  109. Edelstein P, Meyer RD (1980) Susceptibility of Legionella pneumophila to twenty antimicrobial agents. Antimicrob Agents Chemother 18: 403–408

    Article  PubMed  CAS  Google Scholar 

  110. Asscher AW (1980) Course and consequences of covert bacteriuria in pyelonephritis. In: Losse H et al. (eds) Urinary tract infections, vol IV. Stuttgart, New York, pp 100–106

    Google Scholar 

  111. Bailey RR, Gower PE, Roberts AP, de Wardener HE (1971) Prevention of urinary-tract infection with low dose nitrofurantoin. Lancet 2: 1112

    CAS  Google Scholar 

  112. Bailey RR, Abbott GD (1977) Treatment of urinary tract infection with a single dose of amoxicillin. Nephron 18: 316

    Article  PubMed  CAS  Google Scholar 

  113. Charlton CAC, Crowther A, Davies JG, Dynes J, Haward MWA, Mann PG, Rye S (1976) Threeday and tenday chemotherapy for urinary tract infections in general practice. Br Med J 1: 124

    Article  PubMed  CAS  Google Scholar 

  114. Cornelius DR, Lark DL, Stamey TA (1980) Some observations on attachment of E. coli to human vaginal epithelial cells. Pyelonephritis. In: Losse H et al. (eds) Urinary tract infections, vol IV. Stuttgart, New York, pp 40–49

    Google Scholar 

  115. Erikson K, Kjelberg L (1981) Single-dose antibiotics for urinary infections. Lancet 1: 331

    Google Scholar 

  116. Fang LST, Tolkoff-Rubin NE (1978) Efficacy of single dose and conventional amoxycillin therapy in urinary tract infection localized by the antibody coated bacteria technic. N Engl J Med 298: 413

    Article  PubMed  CAS  Google Scholar 

  117. Greenberg RN, Sanders CV, Marier R, Shaik LM, Moise P, Lewis AC (1980) Single dose therapy of urinary tract infection with cefaclor. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract 232)

    Google Scholar 

  118. Grüneberg RN, Leakey A, Bendali MJ, Smellie JM (1975) Bowel flora in urinary tract infection. Effect of chemotherapy with special reference to cotrimaxozole. Kidney Int 8: 122–129

    Google Scholar 

  119. Harding KMG, Ronald AR (1974) A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med 291: 597

    Article  PubMed  CAS  Google Scholar 

  120. Höffler D (1980) Vergleichende therapeutische Untersuchungen von Pivmecillinam und Amoxycillin. Dtsch Med Wochenschr 103: 1108–1110

    Article  Google Scholar 

  121. Höffler D (1978) Amikacin und Gentamicinein kontrollierter Therapievergleich. Dtsch Med Wochenschr 103: 2071–2075

    Article  PubMed  Google Scholar 

  122. Höffler D, Fröhner H (1979) Untersuchungen zur minimal wirksamen Dosis von Bacampicillin bei Harnwegsinfektionen. Dtsch Med Wochenschr 104: 1673–1675

    Article  PubMed  Google Scholar 

  123. Kass EH (1956) Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 59: 56–64

    Google Scholar 

  124. Otten et al. (Hrsg) Antibiotikafibel (1975) Stuttgart

    Google Scholar 

  125. Pearson NJ, McSherry AM, Towner KJ, Cattell WR, O’Grady F (1979) Emergence of Trimethoprim-resistant Enterobacteria in patients receiving long-term Co-trimoxazole for the control of intractable urinary-tract infection. Lancet 2: 1205–1208

    Article  PubMed  CAS  Google Scholar 

  126. Stamey TA, Condy M, Mihara G (1977) Prophylactic efficacy of Nitrofurantoin macrocrystals and Trimethoprim-Sulfamethoxazole in urinary infections. N Engl J Med 296: 780–783

    Article  PubMed  CAS  Google Scholar 

  127. Stamm EW, Counts GW, Wagner KF, Martin D, Gregory D, McKevitt M, Turck M, Holmes KK (1980) Antimicrobial prophylaxis of recurrent urinary tract infections. Ann Intern Med 92: 770–775

    Article  PubMed  CAS  Google Scholar 

  128. Winberg J, Bergström T, Lincoln K, Lidin-Janson G (1973) Treatment trials in urinary tract infection ( UTI) with special reference to the effect of antimicrobials on the fecal and periurethral flora. Clin Nephrol 1: 142–148

    Google Scholar 

  129. Winberg J (1976) Reinfection Relapse: An important distinction in management of urinary tract infection (UTI). In: Kienitz et al. (Hrsg) Hahnenklee-Symposion, Pyelonephritis. Editiones „Roche“, pp 143–151

    Google Scholar 

  130. Witzel L (1971) Vergleichende bakteriologische Untersuchungen von Mittelstrahl-und Blasenpunktionsurin. Med KIM 66: 1410–1412

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. für innere Medizin, Univ.-Spital Zürich, Schweiz

    R. Lüthy, W. Siegenthaler, P. Fuchs, G. Siegenthaler & R. Lüthy

  2. Division des maladies infectieuses, Centre Hospitalier Universitaire Vaudois, Lausanne, Deutschland

    M. P. Glauser

  3. Max-von-Pettenkofer-Institut, Univ. München, Deutschland

    F. Deinhardt

  4. Sandoz Forschungsinstitut, Wien, Österreich

    J. Drews & P. Mayer

  5. Med. Klinik im Klinikum Steglitz, FU Berlin, Deutschland

    H. Lode & H. Schäfer

  6. Max-von-Pettenkofer-Institut für Med. Mikrobiologie, Univ. München, Deutschland

    R. Ruckdeschel

  7. Med. Klinik III, Städt. Kliniken, Darmstadt, Deutschland

    D. Höffler

Authors
  1. R. Lüthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Siegenthaler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Fuchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Siegenthaler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Lüthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. P. Glauser
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Deinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Drews
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Mayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H. Lode
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H. Schäfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R. Ruckdeschel
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. D. Höffler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

K. Miehlke

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lüthy, R. et al. (1981). Neue Entwicklungen in der Behandlung von Infektionskrankheiten. In: Miehlke, K. (eds) Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 87. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-47092-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-47092-9_3

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0327-6

  • Online ISBN: 978-3-642-47092-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation